Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Prostate. 2009 Jun 1;69(8):827–837. doi: 10.1002/pros.20931

Figure 3.

Figure 3

Parthenolide targets prostate tumor-initiating cells in vivo. Figure shows a Kaplan-Meier plot of time to palpable tumor formation. CD44hi (100 cells) were injected into the flank of male, 6-week old NOD/SCID mice and then split into the indicated treatment groups; closed triangle vehicle treated, closed square 10 mg/kg PTL, and closed circle 40 mg/kg PTL.